Medicamen Organics Limited Share Price & Stock Analysis

Medicamen Organics Limited (NSE: MEDIORG) is a New Delhi, Delhi-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹30 Cr, it ranks #4,150 by market cap among the 6,197 Indian listed companies on FinBizNet, and #22 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹23.65 (as of 16 Nov 2026), the share price is 26.1% below its 52-week high of ₹32.00 and 23.8% above its 52-week low of ₹19.10. The share price is down 22.3% over one year and up 1.0% over three months.

Key Metrics

Current Price₹23.65
Market Cap₹30 Cr
NSE SymbolMEDIORG
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E RatioNot meaningful (loss)
Return on Equity-13.66%
Return on Assets-5.22%
52-Week Range₹19.10 – ₹32.00
1-Year Price Change-22.3%
3-Month Price Change+1.0%
Beta (1Y)0.99
HeadquartersNew Delhi, Delhi
Websitewww.medicamenorganics.com

Shareholding and Delivery

Promoters held 54.89% of Medicamen Organics Limited's shares as of Jun 2026, against 59.73% in Mar 2025 (−4.84 percentage points).

About Medicamen Organics Limited

Medicamen Organics Limited develops, manufactures, and distributes a range of pharmaceutical dosage. The company offers anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamin, multimineral, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It also provides skincare, haircare, and cosmetic products under the LOIRE brand. The company markets its products to government and private institutions as contract manufacturer/third party manufacturer; and private pharmaceutical companies through third party distributors or on loan license basis across India; African, CIS, and Southeast Asian Countries; and internationally. Medicamen Organics Limited was formerly known as Panchdeep Pharmaceuticals Limited and changed its name to Medicamen Organics Limited

Products and Services

1. Pharmaceuticals-This segment manufactures pharmaceutical products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Pharmaceuticals-100%

Medicamen Organics Limited vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Medicamen Organics Limited₹30 Crn/m-13.66%—-22.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Medicamen Organics Limited?

Medicamen Organics Limited is trading at ₹23.65, with a market capitalisation of ₹30 Cr.

Which sector does Medicamen Organics Limited belong to?

Medicamen Organics Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Medicamen Organics Limited?

Medicamen Organics Limited has a return on equity of -13.66%.

What is the stock symbol of Medicamen Organics Limited?

Medicamen Organics Limited is listed on the NSE under the symbol MEDIORG.

How has Medicamen Organics Limited's share price moved over the past year?

Medicamen Organics Limited's share price is down 22.3% over one year and up 1.0% over three months. Its 52-week range is ₹19.10 to ₹32.00.

What is the promoter holding in Medicamen Organics Limited?

Promoters held 54.89% of Medicamen Organics Limited's shares as of Jun 2026, against 59.73% in Mar 2025 (−4.84 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.